324 related articles for article (PubMed ID: 31257664)
1. Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide.
Jian W; Mo CH; Yang GL; Li L; Gui C
J Clin Lab Anal; 2019 Oct; 33(8):e22972. PubMed ID: 31257664
[TBL] [Abstract][Full Text] [Related]
2. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.
Wolber T; Maeder M; Rickli H; Riesen W; Binggeli C; Duru F; Ammann P
Eur J Clin Invest; 2007 Jan; 37(1):18-25. PubMed ID: 17181563
[TBL] [Abstract][Full Text] [Related]
4. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
[TBL] [Abstract][Full Text] [Related]
5. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease.
Sakai H; Tsutamoto T; Ishikawa C; Tanaka T; Fujii M; Yamamoto T; Takashima H; Horie M
Circ J; 2007 Apr; 71(4):499-505. PubMed ID: 17384449
[TBL] [Abstract][Full Text] [Related]
6. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Value of N-Terminal Pro B-Type Natriuretic Peptide in Evaluating Obstructive Sleep Apnea in Patients With Coronary Artery Disease.
Liu Y; Huang Z; Huang K; Li G; Luo J; Xu Y; Chen P; Chen J; Wang L
J Clin Sleep Med; 2019 Oct; 15(10):1403-1409. PubMed ID: 31596204
[TBL] [Abstract][Full Text] [Related]
8. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
Hamano K; Abe M; Komi R; Kobayashi S
Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
[TBL] [Abstract][Full Text] [Related]
9. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
[TBL] [Abstract][Full Text] [Related]
10. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
[TBL] [Abstract][Full Text] [Related]
12. Incremental value of B-type natriuretic peptide for detection and risk reclassification of obstructive coronary artery disease on computed tomography angiography.
Kawabe M; Sato A; Hoshi T; Endo M; Yoshida I; Aonuma K
J Cardiol; 2017 Apr; 69(4):671-677. PubMed ID: 27443597
[TBL] [Abstract][Full Text] [Related]
13. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide level is depressed in patients with significant coronary artery disease who have high body mass index.
Hong SN; Ahn Y; Yoon NS; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Int Heart J; 2008 Jul; 49(4):403-12. PubMed ID: 18753724
[TBL] [Abstract][Full Text] [Related]
15. The impact of renal function on the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with coronary artery disease.
Chen F; Li JQ; Ou YW; Xia TL; Huang FY; Chai H; Huang BT; Li Q; Pu XB; Li GY; Peng Y; Chen M; Huang DJ
Cardiol J; 2019; 26(6):696-703. PubMed ID: 29611168
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.
Hong SN; Yoon NS; Ahn Y; Lim SY; Kim YS; Yun KH; Kang DK; Lee SH; Lee YS; Kim KH; Son IS; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Circ J; 2005 Dec; 69(12):1472-6. PubMed ID: 16308494
[TBL] [Abstract][Full Text] [Related]
18. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
[TBL] [Abstract][Full Text] [Related]
19. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
